22:34 , Sep 4, 2018 |  BC Extra  |  Financial News

Another C-suite departure at Immunocore

Chief Strategy and Business Officer Kevin Pojasek has left Immunocore Ltd. (Abingdon, U.K.) to join SV Health Investors as venture partner. Pojasek is the fifth C-level executive to leave the TCR company since former CEO...
21:09 , Jul 16, 2018 |  BC Extra  |  Company News

Management tracks: Cerecor, Sangamo

Neurology play Cerecor Inc. (NASDAQ:CERC) said CFO Mariam Morris is stepping down. She is succeeded by Joe Miller, who was VP of finance at Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Additionally, Cerecor hired...
20:17 , Aug 16, 2017 |  BC Innovations  |  Emerging Company Profile

Aiming horizontal

SciBac Inc. is using old-school genetics to make therapeutic bacteria that can battle pathogenic organisms and antibiotic-resistant infections. The approach uses horizontal gene transfer to move therapeutic genes from newly discovered species into strains already...
07:00 , Oct 13, 2016 |  BC Innovations  |  Translation in Brief

Dodging CARs

Scientists at NIH's National Cancer Institute have discovered a new way in which acute lymphoblastic leukemia (ALL) cells become resistant to CAR T cell therapy: by changing into myeloid cells. The results highlight the remarkable...
07:00 , Oct 12, 2016 |  BC Extra  |  Company News

Management tracks

T cell receptor (TCR) therapy company Immunocore Ltd. (Abingdon, U.K.) hired Paul Fry as CFO. He was director of global finance operations at Vodafone Group plc (NASDAQ:VOD). Global Blood Therapeutics Inc. (NASDAQ:GBT) hired Tricia Suvari...
07:00 , Sep 23, 2013 |  BioCentury  |  Finance

Analyst tracks

Analyst tracks Ian Somaiya will joinNomura in November as a managing director and senior analyst covering U.S. biotechnology. Somaiya was a managing director and lead biotechnology analyst at Piper Jaffray. Banker tracks Peter Fry joined Guggenheim Securities as...
07:00 , Jul 9, 2012 |  BC Week In Review  |  Company News

GeneAssess cancer news

GeneAssess received a commitment for up to $500,000 in pre-seed funding from not-for-profit Foundation Venture Capital Group (FVCG). The newco, which was spun out of the University of Medicine and Dentistry of New Jersey...
08:00 , Jan 2, 2012 |  BioCentury  |  Finance

Small-fry squashed

Among last year's best-performing large cap biotechs were an acquiree and an acquirer: HCV play Pharmasset Inc. and Valeant Pharmaceuticals International Inc. Other big cap stocks also did well overall, while investors abandoned their small-...
08:00 , Feb 14, 2011 |  BC Week In Review  |  Company News

Eli Lilly management update

Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind.   Business: Pharmaceuticals   Transitioned: Sue Mahony, member of the executive and operations committees, to SVP and president of Lilly Oncology from SVP of human resources and diversity, also formerly...
07:00 , Oct 25, 2010 |  BioCentury  |  Finance

Banking on CELoCs

Banking on CELoCs Peter Fry has launched Burrill & Co.'s new alternative equities group, which will offer committed equity lines of credit. He told Ebb & Flow the CELoCs are similar to the committed equity financing...